Systemic Therapy in Advanced Hepatocellular Carcinoma: Patient Selection and Key Considerations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systemic Therapy in Advanced Hepatocellular Carcinoma: Patient Selection and Key Considerations

Published:2022-11 Issue: Volume:Volume 9 Page:1187-1200
ISSN:2253-5969
Container-title:Journal of Hepatocellular Carcinoma
language:en
Short-container-title:JHC

Author:

Storandt Michael H^ORCID,Mahipal Amit,Tella Sri Harsha^ORCID,Kommalapati Anuhya,Jin Zhaohui^ORCID

Publisher

Informa UK Limited

Subject

General Medicine

Reference71 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Cancer statistics, 2022

3. Cancer statistics, 2020

4. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States

5. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sorafenib and Piperine co-loaded PLGA nanoparticles: Development, characterization, and anti-cancer activity against hepatocellular carcinoma cell line;Saudi Pharmaceutical Journal;2024-05

2. Comprehensive analysis of cuproptosis-related long non-coding RNAs in prognosis, immune microenvironment infiltration and chemotherapy response of hepatocellular carcinoma;Medicine;2023-12-15

3. Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma;Oncology;2023-09-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3